Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Sdgla who wrote (1226026)	5/1/2020 5:52:34 PM
From: pocotrader	Read Replies (1) \| Respond to of 1584889

from what I read it could kill you if not administered properly and may not help that much but if I thought i was dying, what the hell, give it a shot

To: Sdgla who wrote (1226026)	5/1/2020 6:37:12 PM
From: Taro	3 Recommendations Recommended By FJB locogringo Thomas M. Read Replies (1) \| Respond to of 1584889

MEDIA LIED, PEOPLE DIED: Italian Study Finds INCREDIBLE Prophylaxis Results for Patients on Hydroxychloroquine @JamesTodaroMD The Italian Society for Rheumatology studied 65,000 patients on longterm hydroxychloroquine for RA and Lupus. Only 20 patients tested positive for COVID-19. No ICU, no deaths. This is a 90% reduction in infection rate compared to the rest of Italy.https://t.co/Pta97oBA8O thegatewaypundit.com